Effect of combination therapy (ribavirin and interferon) in HCV-related glomerulopathy
|
|
- Anis Ramsey
- 6 years ago
- Views:
Transcription
1 Nephrol Dial Transplant (2002) 17: Original Article Effect of combination therapy (ribavirin and interferon) in HCV-related glomerulopathy Alaa A. Sabry 1, Mohamed A. Sobh 1, Hussein A. Sheaashaa 1, Guara Kudesia 2, Graham Wild 2, Samantha Fox 2, Bart E. Wagner 2, William L. Irving 3, Anna Grabowska 3 and Abdel Meguid El-Nahas 3 1 Mansoura Urology and Nephrology Center, Mansoura University, Mansoura, Egypt, 2 Sheffield Kidney Institute, Northern General Hospital, Sheffield and 3 Queen s Medical Centre, Nottingham, UK Abstract Background. Hepatitis C virus (HCV) is a major cause of acute and chronic hepatitis throughout the world. Several extrahepatic manifestations, including glomerulonephritis, have been reported to be associated with this type of infection. Cryoglobulinaemic and non-cryoglobulinaemic membranoproliferative glomerulonephritis (MPGN) and membranous nephropathy (MN) are the commonest lesions associated with HCV. Results of treatment of these patients with interferon therapy have been disappointing, since relapse of the viraemia and subsequent relapse of the renal disease are major problems. Combination of interferon with ribavirin in patients with chronic liver disease has been shown to increase the rate of sustained response. Methods. In this work, 20 patients with HCVassociated glomerulopathy were subjected to an in-depth evaluation of their kidney lesions and HCV involvement. Laboratory, histopathological, immunohistochemical, and electron-microscopy techniques were used. The patients received interferon therapy for 12 months; in interferon-resistant subjects, interferon was combined with ribavirin. Results. MPGN was the commonest kidney lesion, being reported in 85% of these cases, followed by MN and mesangioproliferative glomerulonephritis (10 and 5% respectively). Mixed cryoglobulinaemia was encountered in 60% of the cases. Twelve months antiviral treatment resulted in aviraemia in 25% of cases, while liver enzymes were normalized in 75%, 24-h proteinuria significantly decreased (from median 4 g to 1.10 g, Ps0.001), serum albumin increased (from median 2.50 to 3.55 gudl, Ps0.012), lower viral titres Correspondence and offprint requests to: Dr A. A. Sabry, Mansoura Urology and Nephrology Center, Mansoura University, Mansoura, Egypt. asabry20@hotmail.com (from median 1.15 to 0.53 mega-equml, Ps0.049), and C3 and C4 concentrations returned to normal. Basal serum creatinine and viral titres were important determinants of response to treatment. Conclusion. This study supports the relationship between HCV and glomerulonephritis, especially MPGN, and the use of a combination of interferon and ribavirin in the treatment of selected cases of HCV-related glomerulopathy. Keywords: glomerulopathy; HCV nephropathy; interferon; membranoproliferative glomerulonephritis; ribavirin Introduction Glomerular disease frequently accompanies chronic liver disease, although it is clinically silent [1]. Accumulating epidemiological evidences suggest that there is an association between hepatitis C virus (HCV) infection and renal diseases, most commonly membranoproliferative glomerulonephritis (MPGN) and membranous nephropathy (MN) [2]. Focal segmental glomerulosclerosis (FSGS), mesangial proliferative glomerulonephritis with IgA deposition are especially common [3]. These patients may or may not have cryoglobulinaemia, and even if it is present they frequently lack other symptoms of essential mixed cryoglobulinaemia [4,5]. The results of interferon treatment for HCV-related MPGN have been disappointing [6]. In the great majority of these cases, interferon has been successful in inducing recovery of renal function with reduction of proteinuria, in association with clearance of HCV from the serum. Unfortunately, the disease tends to relapse shortly after therapy is stopped [7,8]. Ribavirin alone has recently been used in the treatment of patients with # 2002 European Renal Association European Dialysis and Transplant Association
2 Interferon-a and ribavirin in HCV-related glomerulopathy HCV-associated mixed cryoglobulinaemia. However, complete and sustained virological response has never been reported [9]. Success of combination therapy in rapid clearance of HCV from serum, resolution of purpura, and marked improvement in renal function and proteinuria has recently been reported in a small group of patients [8]. Thus, we decided to study the effect of combination therapy (interferon plus ribavirin) in a group of patients (ns20) diagnosed with HCV-related glomerulopathy. Patients and methods This study included 20 HCV-infected patients with nephrotic syndrome. All patients were positive for HCV antibodies when screened by a third-generation ELISA technique (Abbott Diagnostics, USA). Confirmation of HCV infection was achieved by polymerase reaction (PCR) (Amplicor PCR Diagnostics, Roche Diagnostic Systems, USA). Other secondary causes of glomerulonephritis such as diabetes mellitus, schistosomiasis, and SLE were excluded. Laboratory investigations included urinalysis, serum electrolytes, creatinine, bilirubin, ALT, AST, and alkaline phosphatase test for rheumatoid factor and cryoglobulinaemia were carried out using standard methods. Additional virological studies included testing for HBsAg by ELISA (Abbott Diagnostics, USA) and HIV 1 and 2 (Murex HCV 1 and 2 immunoassay). Renal biopsies were carried out in all cases, but liver biopsies were obtained from only seven patients with elevated liver enzymes. Two patients with skin lesions were subjected to skin biopsy. Formalin-fixed and paraffin-embedded sections of kidney and liver tissues were stained and examined by light-microscopy. Reverse transcription (RT) polymerase chain reaction (nested PCR) Cryoprecipitates, paraffin-embedded liver and kidney sections, and frozen kidney tissues were tested for HCV- RNA by two round amplification PCR (nested PCR) using primers chosen from the highly conserved 59 region (Life Technologies Ltd, UK) [5,9]. Immunohistochemistry Formalin-fixed, paraffin-embedded liver and renal sections as well as frozen renal sections were subjected to immunohistochemistry using monoclonal antibody to HCV core AA1-120 (Biogenesis Ltd, UK) [5,10]. Electron microscopy Eight renal biopsy sections were randomly chosen and examined by electron microscopy (Philips 400 transmission EM). Kidney sections from three HCV-negative nephrotic patients were included in this test as controls. Viral genotyping HCV genotyping was performed on 10 patients using RT PCR with specific primers for HCV core region 59 NCR. Products were sequenced with AB1 prism DNA sequencing kit (PE Applied Biosciences, Warrington, UK). Anti-viral treatment protocol Interferon-a 2A was given subcutaneously in a dose of 3 MU three times weekly. The dose was adjusted according to patient tolerance. Patients were followed up weekly for 1 month and monthly thereafter for 12 months. Laboratory investigations at follow-up visits included urinalysis, serum creatinine, bilirubin, ALT, AST, alkaline phosphatase, CBC, and 24-h urinary protein excretion. At the 3-month follow-up qualitative HCV-RNA-PCR was carried out (Amplicor PCR diagnostics, Roche Diagnostic System, USA). Those with persistent HCV viraemia were given ribavirin in addition at a dose of 15 mgukguday, with dose modification when indicated. Treatment was continued to the complete 12 months. Quantification of HCV-RNA This was carried out for all patients at the beginning and at the end of anti-viral treatment using HCV-RNA 2.0 assay (bdna) (Chiron Corporation, Emeryville, CA, USA). Results from the Chiron luminometer are reported in relative luminescence units, a measurement of the amount of light emitted from each HCV capture well, which is proportional to the number of HCV-RNA mega-equivalent per millilitre present in the specimen [5]. Renal response to anti-viral treatment According to the renal response to anti-viral treatment, patients were divided into two groups: group I cases were those who showed favourable response (stable or decreased serum creatinine and proteinuria), and group II cases were those who showed a deterioration in their serum creatinine and proteinuria. The two groups were compared to identify factors affecting the renal response to anti-viral treatment. Statistical analysis Results are given as median and confidence intervals. Mann Whitney (non-parametric rank sum test), Fischer exact probability test, and chi-squared test were applied as appropriate. A P-value of was considered significant. Results 1925 General observations The clinical characteristics of the 20 patients with HCV-related glomerulopathy are given in Table 1. Males predominated, blood transfusion was reported in 42% of the cases, and a history of surgery was given in 60% of cases. Laboratory evaluation showed HCV antibodies and HCV-RNA in the serum of all cases, rheumatoid factor was positive in 15 cases while mixed cryoglobulinaemia was detected in 14. Of those with cryoglobulinaemia, extra-renal manifestations were reported in only eight patients, mainly in the form of purpura and arthralgia.
3 1926 A. A. Sabry et al. Fig. 1. HCV antigen detected (arrow) in liver biopsy (avidin biotin peroxidase stain). Table 1. Demographic, clinical, and histological characteristics of 20 patients on interferon-a therapy Characteristic Number Demographic Maleufemale 13u7 Risk factors for HCV: History of hospital admission 10 Blood transfusion 8 Operation 12 History of abnormal liver enzymes 7 Clinical Generalized weakness 10 Peripheral oedema 17 Hepatomegaly 4 Palpable purpura 7 Arthralgias 4 Arterial hypertension 5 Laboratory HCV-RNA in cryoprecipitates 15 Mixed cryoglobulinaemia 14 Rheumatoid factor 15 HCV-RNA 20 HCV-Ab 20 Histological Renal pathology MPGN 7 MN 2 Mesangioproliferative glomerulonephritis 1 Liver biopsy CAH 3 CPH 4 Skin biopsy Acral necrolytic erythema 2 MPGN, membranoproliferative glomerulonephritis; MN, membranous nephropathy; CAH, chronic active hepatitis; CPH, chronic persistent hepatitis. Light microscopy of kidney sections showed mesangiocapillary glomerulonephritis (type 1) in 17 cases, membranous glomerulonephritis in two cases, and mesangioproliferative glomerulonephritis in one case. Light microscopy of liver sections obtained from seven patients showed chronic active hepatitis in three and chronic persistent hepatitis in four cases. Demonstration of HCV in cryoprecipitate, liver, and kidney tissues RT PCR for HCV was positive in the cryoprecipitate of 14 cases, in four of seven formalin-fixed paraffinembedded liver sections, in seven of 20 frozen renal biopsies, but in none of the formalin-fixed paraffin-embedded renal sections. Immunohistochemistry of liver and renal sections demonstrated HCV core AA antigen in two of seven paraffin-embedded liver sections (Figure 1), but not in frozen renal or liver tissue, nor in paraffin-embedded renal tissue. Electron microscopy of eight renal biopsy sections from HCV-positive cases showed immune complexes in the subendothelial and the paramesangial areas (Figure 2). In four of these cases virus-like particles were detected inside these immune complexes (Figures 3 and 4), while in all HCV-negative cases (controls) immune complexes were negative. Of 10 HCV-positive patients examined for viral genotype, sufficient amounts of HCV-RNA were extracted from serum of seven cases only. Genotyping of these cases demonstrated HCV type 4 in all of them. Outcome of anti-viral treatment At 3 months after initiation of interferon treatment, only four of the 20 treated patients showed negative HCV-RNA-PCR. The 16 non-responders were given
4 Interferon-a and ribavirin in HCV-related glomerulopathy 1927 Fig. 2. Electron microscopy for HCV-positive patients with subendothelial and paramesangial electron-dense deposits ( ). Fig. 3. Electron microscopy for HCV-positive patients with viral-like particles inside electron-dense deposits ( ). ribavirin. One of these showed response, while 15 showed persistent viraemia. Table 2 shows the effect of anti-viral treatment on laboratory and serological parameters of the 20 patients. HCV viral titres were significantly lower in treated patients. Also proteinuria, serum albumin, and complement components C3 and C4 were significantly improved after treatment. Of the 20 patients treated by interferon alone or in combination with ribavirin, five showed a progressive deterioration of kidney function and an increase in proteinuria. Table 3 shows, at the commencement of combination therapy, the baseline virological and biochemical parameters of patients who showed stabilization or improvement of kidney function, and their proteinuria on anti-viral treatment (group I), and those who showed deterioration of these parameters (group II). There was a tendency to higher basal viral titres and significantly higher basal serum creatinine concentrations in patients of group II. Table 4 shows adverse effects of anti-hcv treatment. Anaemia was clinically the most significant, and fever occurring early after treatment was the most frequent.
5 1928 A. A. Sabry et al. Fig. 4. Electron microscopy for HCV-positive patient showing virus-like particles inside electron-dense deposits (56 nm) with higher magnification. Table 2. Biochemical characteristics (median and range) of the 20 HCV-infected patients before and after anti-viral therapy Discussion Before After P-value Serum creatinine (mgudl) ( ) ( ) Proteinuria 24 h (g) ( ) ( ) Haemoglobin (gudl) ( ) ( ) Serum albumin (gudl) ( ) ( ) ALT (IUul) ( ) ( ) AST (IUul) ( ) ( ) C3 (mgudl) ( ) ( ) C4 (mgudl) ( ) ( ) HCV viral titre (MEquml) ( ) ( ) This work was conducted on 20 patients with nephrotic syndrome associated with HCV infection documented by both anti-hcv and HCV-RNA-PCR. Light-microscopy examination of kidney biopsies showed MPGN type l in 17 patients, while MN was observed in two and mesangial proliferative glomerulonephritis was documented in one case. The high prevalence of MPGN in our series is consistent with that reported in most of the literature. Schifferli and his colleagues [2] reported accumulating epidemiological evidence suggesting that there is Table 3. Parameters at start of anti-viral treatment (median and confidence intervals) of patients with favourable renal response (group I) and those with unfavourable response (group II) Group I Group II P-value Number Age (years) ( ) ( ) Serum creatinine (mgudl) ( ) ( ) Proteinuria 24 h (g) ( ) ( ) Serum albumin (gudl) ( ) ( ) HCV viral titre (MEquml) ( ) ( ) an association between HCV infection and MPGN and MN. These findings were also reported by others [5,6]. Beside detection of anti-hcv antibodies and viral RNA in the serum of our nephrotic patients, we documented the presence of HCV viral particles in the cryoprecipitate, liver tissue, and kidney tissue specimens. Furthermore, the HCV specificity of these kidney lesions in our patients was supported by regression of proteinuria and normalization of C3 and C4 in response to interferon ribavirin treatment. It seems that the optimal treatment strategy for HCV-associated renal disease remains to be defined. Johnson et al. [7] reported that oral steroids with HCVassociated nephritis had no effect on renal function, although it may have improved the purpura. While pulse steroids were associated with improvement in renal function, these patients remain HCV-RNA
6 Interferon-a and ribavirin in HCV-related glomerulopathy Table 4. Adverse events of interferon and combined interferon ribavirin therapy in patients with HCV-related glomerulopathy Adverse events Interferon therapy Temporary discontinuation 5 1 of therapy Dose reduction Due to anaemia 4 7 Due to other adverse events Flu-like symptoms Headache 2 Fever 17 Gastrointestinal symptoms Anorexia 5 Vomiting 5 Nausea 5 Abdominal pain 1 Psychiatric symptoms Depression 1 1 Insomnia 1 1 Dermatological symptoms Alopecia 1 Combined therapy positive [7]. One problem with such therapy is the increase in HCV-RNA levels with its possible consequences on the underlying liver disease [10]. Cyclophosphamide was successfully used for treatment of the HCV-infected patients with cryoglobulinaemia and progressive renal insufficiency cause by MPGN. Unfortunately HCV-RNA levels increased in these patients [11]. Only a few studies, involving small number of patients, have examined the response of MPGN associated with chronic HCV infection to interferon-a treatment. Results of these studies have been inconsistent [4,7,12]. In our study, 12 months treatment with interferon alone (four patients) or combined with ribavirin (16 patients) resulted in a significant reduction of proteinuria, a rise in serum albumin, stabilization of serum creatinine, normalization of C3 and C4, and significant reduction in viral titres. Beneficial effects of interferon-a therapy on the clinical and biochemical manifestations of type II essential mixed cryoglobulinaemia in some uncontrolled studies [12,13] and in two controlled trials [14,15] had been reported even before the demonstration of the pathogenetic role of HCV infection in this disease. In our study, we observed that the introduction of ribavirin in addition to interferon resulted in little improved virological response (only one patient seroconverted out of 16 patients given the combined treatment); yet a satisfactory biochemical response was achieved in the form of a significant reduction of proteinuria and a rise in serum albumin. A similar observation was reported by Heagy et al. [16]. It was suggested that ribavirin acts on HCV-related glomerular or hepatic lesions through a mechanism other than a reduction in viral replication, Pham et al. [17] suggested that the non-specific effects of ribavirin might prove beneficial in non-viral immune glomerulonephritis. Five of our patients showed exacerbation of their proteinuria with progressive deterioration of renal function while on anti-viral treatment. Comparing these patients with those demonstrating a favourable renal response revealed a significantly higher serum creatinine before starting combination therapy; in addition, their initial viral titres tended to be higher. We have no explanation for this finding. Possibly these patients had a primary glomerular disease in which HCV had no pathogenic role, and this disease is exacerbated by a direct or indirect effect of interferon. Ohta et al. [18] reported exacerbation of glomerulonephritis in patients with chronic HCV infection after interferon therapy. The mechanism is not fully understood. In another study, anti-interferon IgG-antibody was found in the circulation and renal tissue of a patient who developed MPGN after interferon therapy for human immunodeficiency virus infection [19]. In conclusion, our study showed a documented link between cryoglobulinaemic and non-cryoglobulinaemic MPGN and chronic HCV infection. A possible role for HCV infection and other forms of GN requires further study. Detection of HCV-RNA in paraffin-embedded liver and frozen renal tissues is feasible. Biochemical response to interferon therapy in such cases improved when combined with ribavirin. Further studies using higher doses or pegylated forms of interferon on HCV-related MPGN are urgently needed. Acknowledgements. The authors wish to thank Dr Ibrahim Hefni for his generous grant, which covered the cost of all the laboratory work and that of the interferon and ribavirin used in this study. Also, the authors are grateful to the Northern General Hospital Trust Research Committee for its financial support, and acknowledge the secretarial work of Mrs Hend Sharabi. References Crawford DHJ, Endre ZH, Axelsen RA et al. Universal occurrence of glomerular abnormalities in patients receiving liver transplants. Am J Kidney Dis 1992; 19: Schifferli JA, French LE, Tissat JD. HCV infection, cryoglobulinemia, and glomerulonephritis. Adv Nephrol 1995; 24: Altarif IH, Abdalla AS, Alsebayl MI et al. Hepatitis C associated glomerulonephritis. Am J Nephrol 1995; 15: Yamabe H, Johnson RJ, Gretch DR et al. Hepatitis C virus infection and membranoproliferative glomerulonephritis in Japan. J Am Soc Nephrol 1995; 6: Sabry AA, Sobh MA, Irving WL et al. A comprehensive study of the association between hepatitis C virus and glomerulopathy. Nephrol Dial Transplant 2002; 17: Gumber SC, Chopra S. Hepatitis C: A multifaceted disease, Review of Extra hepatic manifestations. Ann Intern Med 1995; 123: Johnson RJ, Gretch DR, Couser WG. Hepatitis associated glomerulonephritis. Effect of alpha-interferon therapy. Kidney Int 1994; 46: Misiani R, Bellavita P, Baio P et al. Successful treatment of HCV-associated cryoglobulinemic glomerulonephritis with a combination of interferon-alpha and ribavirin. Nephrol Dial Transplant 1999; 14: Sansonno D, Gesualdo L, Manno C et al. Hepatitis C virus related proteins in kidney tissue from hepatitis C virus-infected patients with cryoglobulinemic membranoproliferative glomerulonephritis. Hepatology 1997; 25:
7 1930 A. A. Sabry et al. 10. Diamond AD, Davis GL, Qian K-P, Lau JYA. Detection of hepatitis C viral sequences in formalin-fixed, paraffin-embedded liver tissue: effect of interferon Alpha therapy. J Med Virol 1994; 42: Quigg RJ, Brathwaite M, David FG et al. Successful cyclophosphamide treatment of cryoglobulinemic membranoproliferative glomerulonephritis associated with hepatitis C virus infection. Am J Kidney Dis 1995; 25: Johnson RJ, Gretch DR, Yamabe H et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993; 328: Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 19: Misiani R, Bellaviata P, Fenili D, Vicari V et al. Interferon alpha-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994; 330: Ferri C, Marzo E, Longobardo G. Interferon-alpha in mixed cryoglobulinemia patients: a randomized, cross-over controlled trial. Blood 1993; 81: Heagy W, Crumpacker C, Lopez PA, Finberg RW. Inhibition of immune function by antiviral drugs. J Clin Invest 1991; 87: Pham HP, Feray C, Samul D et al. Effect of ribavirin on hepatitis C associated nephrotic syndrome in four liver transplant recipients. Kidney Int 1998; 54: Ohta S, Yokoyama H, Wada T et al. Exacerbation of glomerulonephritis in subjects with chronic hepatitis C virus infection after interferon therapy. Am J Kidney Dis 1999; 6: Kimmel PI, Abraham AA, Philips TM. Membranoproliferative glomerulonephritis in patients treated with interferon-alpha for human immunodeficiency virus infection. Am J Kidney Dis 1994; 24: Received for publication: Accepted in revised form:
Therapy With Interferon-α Plus Ribavirin for Membranoproliferative Glomerulonephritis Induced by Hepatitis C Virus
BJID ; 7 (October) 5 Therapy With Interferon-α Plus Ribavirin for Membranoproliferative Glomerulonephritis Induced by Hepatitis C Virus Edmundo P.A. Lopes, Lucila M. Valente, Divisions of Gastroenterology
More informationC ( Hepatitis C virus ) ( Membranoproliferative glomerulonephritis ) ( Membranous nephropathy ) ( Focal segmental glomerulosclerosis )
06 17 259-263 ( extrahepatic manifestations ) ( membranoproliferative glomerulonephritis ) ( membranous nephropathy ) ( focal segmental glomerulosclerosis ) ( immunosuppressive therapy ) ( plasma-exchange
More informationCase Presentation Turki Al-Hussain, MD
Case Presentation Turki Al-Hussain, MD Director, Renal Pathology Chapter Saudi Society of Nephrology & Transplantation Consultant Nephropathologist & Urological Pathologist Department of Pathology & Laboratory
More informationconsidered for patients with cryoglobulinemic kidney diseases. (Weak)
http://www.kidney-international.org & 2008 DIGO Guideline 5: Diagnosis and management of kidney diseases associated with HCV infection idney International (2008) 73 (Suppl 109), S69 S77; doi:10.1038/ki.2008.88
More informationFIBRILLARY GLOMERULONEPHRITIS DIAGNOSTIC CRITERIA, PITFALLS, AND DIFFERENTIAL DIAGNOSIS
FIBRILLARY GLOMERULONEPHRITIS DIAGNOSTIC CRITERIA, PITFALLS, AND DIFFERENTIAL DIAGNOSIS Guillermo A. Herrera MD Louisiana State University, Shreveport Fibrils in bundles 10-20 nm d Diabetic fibrillosis
More informationCase 3. ACCME/Disclosure. Laboratory results. Clinical history 4/13/2016
Case 3 Lynn D. Cornell, M.D. Mayo Clinic, Rochester, MN Cornell.Lynn@mayo.edu USCAP Renal Case Conference March 13, 2016 ACCME/Disclosure Dr. Cornell has nothing to disclose Clinical history 57-year-old
More informationGOODPASTURE'S SYNDROME WITH CONCOMITANT IMMUNE COMPLEX MIXED MEMBRANOUS AND PROLIFERATIVE GLOMERULONEFRITIS
GOODPASTURE'S SYNDROME WITH CONCOMITANT IMMUNE COMPLEX MIXED MEMBRANOUS AND PROLIFERATIVE GLOMERULONEFRITIS VESNA JURČIĆ 1, ANDREJA ALEŠ RIGLER 2, INSTITUTE OF PATHOLOGY, FACULTY OF MEDICINE, UNIVERSITY
More informationMonoclonal Gammopathies and the Kidney. Tibor Nádasdy, MD The Ohio State University, Columbus, OH
Monoclonal Gammopathies and the Kidney Tibor Nádasdy, MD The Ohio State University, Columbus, OH Monoclonal gammopathy of renal significance (MGRS) Biopsies at OSU (n=475) between 2007 and 2016 AL or AH
More informationC1q nephropathy the Diverse Disease
C1q nephropathy the Diverse Disease Danica Galešić Ljubanović School of Medicine, University of Zagreb Dubrava University Hospital Zagreb, Croatia Definition Dominant or codominant ( 2+), mesangial staining
More informationRECURRENT AND DE NOVO RENAL DISEASES IN THE ALLOGRAFT. J. H. Helderman,MD,FACP,FAST
RECURRENT AND DE NOVO RENAL DISEASES IN THE ALLOGRAFT J. H. Helderman,MD,FACP,FAST Vanderbilt University Medical Center Professor of Medicine, Pathology and Immunology Medical Director, Vanderbilt Transplant
More informationAdditional file 2: Details of cohort studies and randomised trials
Reference Randomised trials Ye et al. 2001 Abstract 274 R=1 WD=0 Design, numbers, treatments, duration Randomised open comparison of: (45 patients) 1.5 g for 3, 1 g for 3, then 0.5 to 0.75 g IV cyclophosphamide
More informationGlomerular diseases with organized deposits
Glomerular diseases with organized deposits Banu Sis, MD, FRCPC University of Alberta, Edmonton, AB, Canada Ulusal Patoloji Kongresi, Manavgat, Antalya 8/11/2012 What is an organized deposit? A number
More informationCase Presentation Turki Al-Hussain, MD
Case Presentation Turki Al-Hussain, MD Director, Renal Pathology Chapter Saudi Society of Nephrology & Transplantation Consultant Nephropathologist & Urological Pathologist Department of Pathology & Laboratory
More informationDr Ian Roberts Oxford. Oxford Pathology Course 2010 for FRCPath Illustration-Cellular Pathology. Oxford Radcliffe NHS Trust
Dr Ian Roberts Oxford Oxford Pathology Course 2010 for FRCPath Present the basic diagnostic features of the commonest conditions causing proteinuria & haematuria Highlight diagnostic pitfalls Nephrotic
More informationPegylated Interferon Alfa-2b (Peg-Intron) Plus Ribavirin (Rebetol)in the Treatment of Chronic Hepatitis C: A Local Experience
Pegylated Interferon Alfa-2b (Peg-Intron) Plus Ribavirin (Rebetol)in the Treatment of Chronic Hepatitis C: A Local Experience E L Seow, PH Robert Ding Island Hospital, Penang, Malaysia. Introduction Hepatitis
More informationManagement of HBV in KidneyTransplanted Patients Dr.E.Nemati
Management of HBV in KidneyTransplanted Patients Dr.E.Nemati Hepatitis B virus (HBV) infection Hepatitis B virus (HBV) infection confers a significantly negative impact on the clinical outcomes of kidney
More informationGlomerular Pathology- 1 Nephrotic Syndrome. Dr. Nisreen Abu Shahin
Glomerular Pathology- 1 Nephrotic Syndrome Dr. Nisreen Abu Shahin The Nephrotic Syndrome a clinical complex resulting from glomerular disease & includes the following: (1) massive proteinuria (3.5 gm /day
More informationSteroid Resistant Nephrotic Syndrome. Sanjeev Gulati, Debashish Sengupta, Raj K. Sharma, Ajay Sharma, Ramesh K. Gupta*, Uttam Singh** and Amit Gupta
Steroid Resistant Nephrotic Syndrome Sanjeev Gulati, Debashish Sengupta, Raj K. Sharma, Ajay Sharma, Ramesh K. Gupta*, Uttam Singh** and Amit Gupta From the Departments of Nephrology, Pathology* and Biostatistics**,
More informationElevated Serum Creatinine, a simplified approach
Elevated Serum Creatinine, a simplified approach Primary Care Update Creighton University School of Medicine. April 27 th, 2018 Disclosure Slide I have no disclosures and have no conflicts with this presentation.
More informationGlomerular pathology in systemic disease
Glomerular pathology in systemic disease Lecture outline Lupus nephritis Diabetic nephropathy Glomerulonephritis Associated with Bacterial Endocarditis and Other Systemic Infections Henoch-Schonlein Purpura
More informationCommonly Asked Questions About Chronic Hepatitis C
Commonly Asked Questions About Chronic Hepatitis C From the American College of Gastroenterology 1. How common is the hepatitis C virus? The hepatitis C virus is the most common cause of chronic viral
More informationTubulointerstitial nephritis associated with hepatitis C virus infection
CASE REPORT Advance Access publication 25 March 2009 Tubulointerstitial nephritis associated with hepatitis C virus infection Ana Oliveira, Raquel Cabral, Susana Sampaio, Manuela Bustorff, Manuel Pestana
More informationGlomerular diseases mostly presenting with Nephritic syndrome
Glomerular diseases mostly presenting with Nephritic syndrome 1 The Nephritic Syndrome Pathogenesis: proliferation of the cells in glomeruli & leukocytic infiltrate Injured capillary walls escape of RBCs
More informationCHAPTER 2 PRIMARY GLOMERULONEPHRITIS
CHAPTER 2 Sunita Bavanandan Lim Soo Kun 19 5th Report of the 2.1: Introduction This chapter covers the main primary glomerulonephritis that were reported to the MRRB from the years 2005-2012. Minimal change
More informationSpecial Challenges and Co-Morbidities
Special Challenges and Co-Morbidities Renal Disease/ Hypertension/ Diabetes in African-Americans M. Keith Rawlings, MD Medical Director Peabody Health Center AIDS Arms, Inc Dallas, TX Chair, Internal Medicine
More informationSecondary IgA Nephropathy & HSP
Secondary IgA Nephropathy & HSP Anjali Gupta, MD 1/11/11 AKI sec to Hematuria? 65 cases of ARF after an episode of macroscopic hematuria have been reported in the literature in patients with GN. The main
More informationA clinical syndrome, composed mainly of:
Nephritic syndrome We will discuss: 1)Nephritic syndrome: -Acute postinfectious (poststreptococcal) GN -IgA nephropathy -Hereditary nephritis 2)Rapidly progressive GN (RPGN) A clinical syndrome, composed
More informationGlomerular pathology-2 Nephritic syndrome. Dr. Nisreen Abu Shahin
Glomerular pathology-2 Nephritic syndrome Dr. Nisreen Abu Shahin 1 The Nephritic Syndrome Pathogenesis: inflammation proliferation of the cells in glomeruli & leukocytic infiltrate Injured capillary walls
More informationPathology of Complement Mediated Renal Disease
Pathology of Complement Mediated Renal Disease Mariam Priya Alexander, MD Associate Professor of Pathology GN Symposium Hong Kong Society of Nephrology July 8 th, 2017 2017 MFMER slide-1 The complement
More informationRenal Pathology 1: Glomerulus. With many thanks to Elizabeth Angus PhD for EM photographs
Renal Pathology 1: Glomerulus With many thanks to Elizabeth Angus PhD for EM photographs Anatomy of the Kidney http://www.yalemedicalgroup.org/stw/page.asp?pageid=stw028980 The Nephron http://www.beltina.org/health-dictionary/nephron-function-kidney-definition.html
More informationCHAPTER 2. Primary Glomerulonephritis
2nd Report of the PRIMARY GLOMERULONEPHRITIS CHAPTER 2 Primary Glomerulonephritis Sunita Bavanandan Lee Han Wei Lim Soo Kun 21 PRIMARY GLOMERULONEPHRITIS 2nd Report of the 2.1 Introduction This chapter
More informationHCV Treat now! Robert G Gish MD. Professor Consultant Stanford University
HCV Treat now! Robert G Gish MD Professor Consultant Stanford University Steering committee and Executive Board NVHR National Viral Hepatitis Roundtable Founding Member CEVHAP Singapore Viral Hepatitis
More informationFamilial DDD associated with a gain-of-function mutation in complement C3.
Familial DDD associated with a gain-of-function mutation in complement C3. Santiago Rodríguez de Córdoba, Centro de investigaciones Biológicas, Madrid Valdés Cañedo F. and Vázquez- Martul E., Complejo
More informationChronic Hepatitis C. Risk Factors
Chronic Hepatitis C The hepatitis C virus is one of the most important causes of chronic liver disease in the United States. Almost 4 million Americans or 1.8 percent of the U.S. population have an antibody
More informationChronic Active Hepatitis B with HBV- Associated Nephropathy: Close Resemblance to Lupus Nephritis
Chronic Active Hepatitis B with HBV- Associated Nephropathy: Close Resemblance to Lupus Nephritis Amitesh Aggarwal a, Mukul P. Agarwal a, Surendra Rajpal a, Vineeta V. Batra b, Ankit Kumar Sahu a a Department
More informationProteinuria After Kidney Transplantation Its Relation to Hepatitis C Virus and Graft Outcome
transplantation Proteinuria After Kidney Transplantation Its Relation to Hepatitis C Virus and Graft Outcome Alaa Sabry, 1 Rashad Hassan, 1 Ihab Mahmoud, 1 Magdy Hamed, 2 Mohamed Sobh 1 Original Paper
More informationRECURRENT AND DE NOVO RENAL DISEASES IN THE ALLOGRAFT
RECURRENT AND DE NOVO RENAL DISEASES IN THE ALLOGRAFT HISTOPATHOLOGIC DISORDERS AFFECTING THE ALLOGRAFT OTHER THAN REJECTION RECURRENT DISEASE DE NOVO DISEASE TRANSPLANT GLOMERULOPATHY Glomerular Non-glomerular
More informationThe CARI Guidelines Caring for Australasians with Renal Impairment. Idiopathic membranous nephropathy: use of other therapies GUIDELINES
Idiopathic membranous nephropathy: use of other therapies Date written: July 2005 Final submission: September 2005 Author: Merlin Thomas GUIDELINES No recommendations possible based on Level I or II evidence
More informationYear 2004 Paper one: Questions supplied by Megan
QUESTION 53 Endothelial cell pathology on renal biopsy is most characteristic of which one of the following diagnoses? A. Pre-eclampsia B. Haemolytic uraemic syndrome C. Lupus nephritis D. Immunoglobulin
More informationOverview of glomerular diseases
Overview of glomerular diseases *Endothelial cells are fenestrated each fenestra: 70-100nm in diameter Contractile, capable of proliferation, makes ECM & releases mediators *Glomerular basement membrane
More informationHEPATITIS C AND B VIRUS INFECTION AMONG CHRONIC RENAL FAILURE PATIENTS UNDERGOING HAEMODIALYSIS IN CALICUT, KERALA STATE, INDIA.
HEPATITIS C AND B VIRUS INFECTION AMONG CHRONIC RENAL FAILURE PATIENTS UNDERGOING HAEMODIALYSIS IN CALICUT, KERALA STATE, INDIA. Shabana Razmin, SRM Medical College Hospital and Research Centre, Kattankulathur,
More informationViral hepatitis. Supervised by: Dr.Gaith. presented by: Shaima a & Anas & Ala a
Viral hepatitis Supervised by: Dr.Gaith presented by: Shaima a & Anas & Ala a Etiology Common: Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Less common: Cytomegalovirus EBV Rare: Herpes
More informationAssessing the patient with a new diagnosis of Hepatitis C LAUREN MYERS MMSC, PA-C OREGON HEALTH & SCIENCE UNIVERSITY
Assessing the patient with a new diagnosis of Hepatitis C LAUREN MYERS MMSC, PA-C OREGON HEALTH & SCIENCE UNIVERSITY Disclosures Nothing to Disclose Assessing the patient with a new diagnosis of Hepatitis
More informationHEPATITIS C VIRUS GENOTYPING IN CHRONIC HEPATITIS C PATIENTS
HEPATITIS C VIRUS GENOTYPING IN CHRONIC HEPATITIS C PATIENTS I. Qattan Centres for Hepatology, Royal Free & University College Medical School, London V. Emery Department of Virology, Royal Free & University
More informationEnterprise Interest Nothing to declare
Enterprise Interest Nothing to declare Minimal change disease (MCD) related new electron microscopy findings in a patient on Levothyroxine sodium (LT) for hypothyroidism: A case report Dr. Ali Al-Omari
More informationLaboratory and Clinical Diagnosis of HCV Infection
Laboratory and Clinical Diagnosis of HCV Infection Jean-Michel Pawlotsky,, MD, PhD Department of Virology (EA 3489) Henri Mondor Hospital University of Paris XII Créteil,, France I Nonspecific Liver Tests
More informationSECONDARY GLOMERULONEPHRITIDES
SECONDARY GLOMERULONEPHRITIDES This review of the secondary glomerulonephritides outlines presentation clues to assist the primary healthcare worker in making the diagnosis. Glomerulonephritis (GN) due
More informationIdiopathic minimal change nephrotic syndrome in older adults: steroid responsiveness and pattern of relapses
Nephrol Dial Transplant (2003) 18: 1316 1320 DOI: 10.1093/ndt/gfg134 Original Article Idiopathic minimal change nephrotic syndrome in older adults: steroid responsiveness and pattern of relapses Kai-Chung
More informationACCME/Disclosure. Case #1. Case History. Dr. Bracamonte has nothing to disclose
Case #1 ACCME/Disclosure Dr. Erika Bracamonte Associate Professor of Pathology University of Arizona, College of Medicine Banner University Medical Center, Tucson Dr. Bracamonte has nothing to disclose
More informationHIV ASSOCIATED NEPHROPATHIES (HIVAN): 30 YEARS LATER
HIV ASSOCIATED NEPHROPATHIES (HIVAN): 30 YEARS LATER Gaston Zilleruelo M.D. Professor of Pediatrics Director of Pediatric Nephrology University of Miami/Holtz Children s Hospital Worldwide 33.2 million
More informationCASE 4 A RARE CASE OF INTRALUMINAL GLOMERULAR CAPILLARY DEPOSITS
CASE 4 A RARE CASE OF INTRALUMINAL GLOMERULAR CAPILLARY DEPOSITS DR ANNIE JOJO, Dr Seethalekshmy N V, Dr Nanda Kachare DEPARTMENT OF PATHOLOGY, AMRITA INSTITUTE OF MEDICAL SCIENCES, KOCHI. 54 yrs female,
More informationComplement in vasculitis and glomerulonephritis. Andy Rees Clinical Institute of Pathology Medical University of Vienna
Complement in vasculitis and glomerulonephritis Andy Rees Clinical Institute of Pathology Medical University of Vienna 41 st Heidelberg Nephrology Seminar March 2017 The complement system An evolutionary
More informationMembranous nephropathy. By Mohammed Kamal Nassar, MD Lecturer of Nephrology Mansoura University
Membranous nephropathy By Mohammed Kamal Nassar, MD Lecturer of Nephrology Mansoura University Membranous nephropathy Definition: Immune complex glomerular disease in which immune deposits of IgG and complement
More informationNephrotic syndrome in children. Bashir Admani KPA Nephrology Precongress 24/4/2018
Nephrotic syndrome in children Bashir Admani KPA Nephrology Precongress 24/4/2018 What is Nephrotic syndrome?? Nephrotic syndrome is caused by renal diseases that increase the permeability across the glomerular
More informationPattern of Glomerular Diseases in Gombe, Northeastern Nigeria
SHORT COMMUNICATION Pattern of Glomerular Diseases in Gombe, Northeastern Nigeria 1 2 1 2 2 1 3 Sulaiman MM, Lawan AI, Bakki B, Abdullahi YM, Aliyu UB, Sanni IO, Ummate I, 4 5 6 Usman AU, Shettima J, Pindiga
More informationCase # 2 3/27/2017. Disclosure of Relevant Financial Relationships. Clinical history. Clinical history. Laboratory findings
Case # 2 Christopher Larsen, MD Arkana Laboratories Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education Committee) in a position to influence or control the content
More informationNephrotic Syndrome. Department of pediatrics The first affiliated hospital Sun Yat Sen University. Yue Zhihui ( 岳智慧 )
Nephrotic Syndrome Department of pediatrics The first affiliated hospital Sun Yat Sen University Yue Zhihui ( 岳智慧 ) yuezhihui810@yahoo.com.cn Contents Definition Pathophysiology Clinical manifestation
More informationUrinary CD80 as a Replacement for Renal Biopsy for Diagnosis of Pediatric Minimal Change Disease
KIDNEY DISEASES Urinary CD80 as a Replacement for Renal Biopsy for Diagnosis of Pediatric Minimal Change Disease Heba Mostafa Ahmed, 1 Dina Ahmed Ezzat, 1 Noha A Doudar, 2 Mai Adel 1 1 Departement of Pediatrics,
More informationSPECTRUM OF GLOMERULAR DISEASES: AN 11 YEAR RETROSPECTIVE REVIEW IN A TERTIARY CARE HOSPITAL IN PAKISTAN.
Original Article AN 11 YEAR RETROSPECTIVE REVIEW IN A TERTIARY CARE HOSPITAL IN PAKISTAN. * * * Naila Asif, Kunwer Naveed Mukhtar, Farzana Adnan * Assistant Professor, Consultant Nephrologist, Department
More informationA "State-of-the-Art" Conference Hepatitis C: A Meeting Ground for the Generalist and the Specialist
A "State-of-the-Art" Conference Hepatitis C: A Meeting Ground for the Generalist and the Specialist Information regarding pathogenesis and appropriate management of chronic hepatitis C continues to evolve.
More informationTransmission of HCV in the United States (CDC estimate)
Transmission of HCV in the United States (CDC estimate) Past and Future US Incidence and Prevalence of HCV Infection Decline among IDUs Overall incidence Overall prevalence Infected 20+ years Armstrong
More information1.0 Abstract. Title. Keywords
1.0 Abstract Title Real World Evidence of the Effectiveness of Paritaprevir/r Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients with Chronic Hepatitis C - An Observational Study in Austria (REAL) Keywords
More informationClinical and pathological characteristics of patients with glomerular diseases at a university teaching hospital: 5-year prospective review
Clinical and pathological characteristics of patients with glomerular diseases at a university teaching hospital: 5-year prospective review KW Chan, TM Chan, IKP Cheng Objective. To examine the prevalence
More informationTHE URINARY SYSTEM. The cases we will cover are:
THE URINARY SYSTEM The focus of this week s lab will be pathology of the urinary system. Diseases of the kidney can be broken down into diseases that affect the glomeruli, tubules, interstitium, and blood
More informationTHE URINARY SYSTEM. The cases we will cover are:
THE URINARY SYSTEM The focus of this week s lab will be pathology of the urinary system. Diseases of the kidney can be broken down into diseases that affect the glomeruli, tubules, interstitium, and blood
More informationPapers. Clinical application of the Quantiplex HCV RNA 2.0 and Amplicor HCV Monitor assays for quantifying serum hepatitis C virus RNA
J Clin Pathol 1999;52:807 811 807 Papers Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical College Hospital, No 100, Shih-Chuan 1st Rd, Kaohsiung, Taiwan, Republic of China M-L
More informationDepartment of Internal Medicine, Pordenone General Hospital, Italy; 2
Le Infezioni in Medicina, n. 4, 337-341, Caso clinico Case reports Recombinant Human Erythropoietin (RHuEpo) and Granular Colony Stimulating Factor (G-CSF) in hepatitis C virus (HCV) related to mixed cryoglobulinaemia
More informationUse of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome
Pediatr Nephrol (2003) 18:833 837 DOI 10.1007/s00467-003-1175-4 BRIEF REPORT Gina-Marie Barletta William E. Smoyer Timothy E. Bunchman Joseph T. Flynn David B. Kershaw Use of mycophenolate mofetil in steroid-dependent
More informationRaDaR Inclusion and Exclusion Criteria. Diagnosis Inclusion Criteria Exclusion Criteria. Alport Syndrome definite or probable
Alport Syndrome and Type IV collagenopathies APRT Deficiency Alport Syndrome definite or probable Alport carrier definite or probable Thin basement membrane nephropathy APRT Deficiency confirmed Abolished
More informationPrise en charge actuelle de l'hépatite C et nouvelles approches thérapeutiques
Prise en charge actuelle de l'hépatite C et nouvelles approches thérapeutiques Future Complications of Darius Moradpour Service de Gastro-entérologie et d'hépatologie Centre Hospitalier Universitaire Vaudois
More informationOverview of Hepatitis C Virus: The Challenge & The Opportunity. Cody A. Chastain, MD
Overview of Hepatitis C Virus: The Challenge & The Opportunity Cody A. Chastain, MD Disclosures Research supported by Gilead Sciences Inc.: Site investigator for HIV/HCV SWITCH Registry Study Key faculty
More informationBK virus infection in renal transplant recipients: single centre experience. Dr Wong Lok Yan Ivy
BK virus infection in renal transplant recipients: single centre experience Dr Wong Lok Yan Ivy Background BK virus nephropathy (BKVN) has emerged as an important cause of renal graft dysfunction in recent
More informationC3 GLOMERULOPATHIES. Budapest Nephrology School Zoltan Laszik
C3 GLOMERULOPATHIES Budapest Nephrology School 8.30.2018. Zoltan Laszik 1 Learning Objectives Familiarize with the pathogenetic mechanisms of glomerular diseases Learn the pathologic landscape and clinical
More information-HCV genome is about 9400 nucleotides long, it is ssrna and positive sense -the 10 viral proteins are first made as a large polyprotein -individual
2013: HCV Genome -HCV genome is about 9400 nucleotides long, it is ssrna and positive sense -the 10 viral proteins are first made as a large polyprotein -individual proteins are released from polyprotein
More informationTreatment Aspects of Primary Nephrotic Syndrome in Adults
& Treatment Aspects of Primary Nephrotic Syndrome in Adults Senija Rašić*¹, Snježana Unčanin¹, Jasminka Džemidžić¹, Kenana Aganović¹, Amira Srna¹, Ismar Rašić² 1. Institute for Nephrology, Clinical Centre
More informationRenal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis
Kidney International, Vol. 54 (1998), pp. 650 671 NEPHROLOGY FORUM Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis Principal discussant: GIUSEPPE D AMICO San Carlo Borromeo
More informationHistopathology: Glomerulonephritis and other renal pathology
Histopathology: Glomerulonephritis and other renal pathology These presentations are to help you identify basic histopathological features. They do not contain the additional factual information that you
More informationTHE KIDNEY AND SLE LUPUS NEPHRITIS
THE KIDNEY AND SLE LUPUS NEPHRITIS JACK WATERMAN DO FACOI 2013 NEPHROLOGY SIR RICHARD BRIGHT TERMINOLOGY RENAL INSUFFICIENCY CKD (CHRONIC KIDNEY DISEASE) ESRD (ENDSTAGE RENAL DISEASE) GLOMERULONEPHRITIS
More informationNephrology Grand Rounds. Mansi Mehta November 24, 2015
Nephrology Grand Rounds Mansi Mehta November 24, 2015 Case 51yo F with PMH significant for Hypertension referred to renal clinic for evaluation of elevated Cr. no known history of CKD; baseline creatinine
More informationMr. I.K 58 years old
Mr. I.K 58 years old Hospitalized because of marked pitting peripheral edema (bilateral crural and perimalleolar edema) and uncontrolled blood pressure (BP 150/100 mmhg under treatment). since age 54 years
More informationPATTERNS OF RENAL INJURY
PATTERNS OF RENAL INJURY Normal glomerulus podocyte Glomerular capillaries electron micrograph THE CLINICAL SYNDROMES 1. The Nephrotic Syndrome 2. The Acute Nephritic Syndrome 3. Rapidly Progressive Glomerulonephritis
More informationResearch Article Hepatitis B Virus-Related Glomerulonephritis: Not a Predominant Cause of Proteinuria in Korean Patients with Chronic Hepatitis B
Gastroenterology Research and Practice Volume 2015, Article ID 126532, 6 pages http://dx.doi.org/10.1155/2015/126532 Research Article Hepatitis B Virus-Related Glomerulonephritis: Not a Predominant Cause
More informationJournal of Nephropathology
www.nephropathol.com DOI:10.12860/JNP.2013.36 J Nephropathology. 2013; 2(4): 217-233 Journal of Nephropathology Hepatitis C virus infection in nephrology patients Lionel Rostaing 1,2,3,*, Jacques Izopet
More informationCHAPTER 4. Paediatric Renal Biopsies
2nd Report of the Malaysian Registry of Renal Biopsy 2008 PAEDIATRIC RENAL BIOPSIES CHAPTER 4 Paediatric Renal Biopsies Lee Ming Lee Lim Yam Ngo Lynster Liaw Susan Pee Wan Jazilah Wan Ismail Yap Yok Chin
More informationRENAL HISTOPATHOLOGY
RENAL HISTOPATHOLOGY Peter McCue, M.D. Department of Pathology, Anatomy & Cell Biology Sidney Kimmel Medical College There are no conflicts of interest. 1 Goals and Objectives! Goals Provide introduction
More informationThe CARI Guidelines Caring for Australasians with Renal Impairment. Membranous nephropathy role of steroids GUIDELINES
Membranous nephropathy role of steroids Date written: July 2005 Final submission: September 2005 Author: Merlin Thomas GUIDELINES There is currently no data to support the use of short-term courses of
More informationClinical Outcomes of Renal Transplantation in Hepatitis C Virus Positive Recipients
Original Research Article Clinical Outcomes of Renal Transplantation in Hepatitis C Virus Positive Recipients Surendran Sujit 1*, N. Gopalakrishnan 2 1 Assistant Professor, 2 Professor and Head Department
More informationDisorders of the kidney. Urine analysis. Nephrotic and nephritic syndrome.
Disorders of the kidney. Urine analysis. Nephrotic and nephritic syndrome. Azotemia and Urinary Abnormalities Disturbances in urine volume oliguria, anuria, polyuria Abnormalities of urine sediment red
More informationApproach to Glomerular Diseases: Clinical Presentation Nephrotic Syndrome Nephritis
GLOMERULONEPHRITIDES Vivette D Agati Jai Radhakrishnan Approach to Glomerular Diseases: Clinical Presentation Nephrotic Syndrome Nephritis Heavy Proteinuria Renal failure Low serum Albumin Hypertension
More informationIntron A (interferon alfa-2b) with ribavirin, (Moderiba, Rebetol, Ribasphere, RibaTab, ribavirin tablets/capsules - all strengths)
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.01.06 Subject: Intron A Ribavirin Page: 1 of 6 Last Review Date: March 18, 2016 Intron A Ribavirin Description
More informationNephrotic Syndrome NS
Nephrotic Syndrome NS By : Dr. Iman.M. Mudawi Pediatric Nephrology Unit Gaafar Ibn Auf Hospital Definitions: In children NS is applied to any condition with a triad of: Heavy proteinuria (UACR ratio >200
More informationN. Hiramatsu, T. Kuroiwa, H. Ikeuchi, A. Maeshima, Y. Kaneko, K. Hiromura, K. Ueki and Y. Nojima
Rheumatology 28;47:72 77 Advance Access publication 4 April 28 doi:1.193/rheumatology/ken19 Revised classification of lupus nephritis is valuable in predicting renal outcome with an indication of the proportion
More informationLong-term follow-up of juvenile acute nonproliferative glomerulitis (JANG)
Pediatr Nephrol (2007) 22:1957 1961 DOI 10.1007/s00467-007-0555-6 BRIEF REPORT Long-term follow-up of juvenile acute nonproliferative glomerulitis (JANG) Teruo Fujita & Kandai Nozu & Kazumoto Iijima &
More informationNovedades en el tratamiento de la hepatitis B: noticias desde la EASL. Maria Buti Hospital Universitario Valle Hebrón Barcelona
Novedades en el tratamiento de la hepatitis B: noticias desde la EASL Maria Buti Hospital Universitario Valle Hebrón Barcelona Milestones in CHB treatment Conventional IFN 1991 Lamivudine (LAM) 1998 Adefovir
More informationImmunofluorescence Studies of Renal Biopsies
Immunofluorescence Studies of Renal Biopsies * Das RK, 1 Saleh AF, 2 Kabir AN, 3 Talukder SI, 4 Kamal M 5 Immunofluorescence microscopy is the important tool for the diagnosis of glomerular diseases. Direct
More informationViral Hepatitis Diagnosis and Management
Viral Hepatitis Diagnosis and Management CLINICAL BACKGROUND Viral hepatitis is a relatively common disease (25 per 100,000 individuals in the United States) caused by a diverse group of hepatotropic agents
More informationCASE OF THE WEEK 1
www.nephro-pathology.com CASE OF THE WEEK 1 Clinical Presentation: A 17 year old Indian boy presented with anasarca, decreased urine output and episodes of nausea and vomiting over the last three weeks.
More informationTechnology appraisal guidance Published: 22 September 2010 nice.org.uk/guidance/ta200
Peginterferon alfa and ribavirin for the treatment of chronic hepatitis C Technology appraisal guidance Published: 22 September 2010 nice.org.uk/guidance/ta200 NICE 2018. All rights reserved. Subject to
More informationRecurrent Idiopathic Membranous Glomerulonephritis After Kidney Transplantation and Successful Treatment With Rituximab
TRANSPLANTATION Recurrent Idiopathic Membranous Glomerulonephritis After Kidney Transplantation and Successful Treatment With Rituximab Khadijeh Makhdoomi, 1,2 Saeed Abkhiz, 1,2 Farahnaz Noroozinia, 1,3
More informationJ Nephropharmacol. 2014; 3(2): Journal of Nephropharmacology
J Nephropharmacol. 2014; 3(2): 33 37. NPJ Journal of Nephropharmacology Pathological patterns of mesangioproliferative glomerulonephritis seen at a tertiary care center Ghadeer A. Mokhtar 1*, Sawsan Jalalah
More information